Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects
Sarcoidosis is a heterogeneous disease in terms of presentation, duration, and severity. Due to this heterogeneity, it is difficult to align treatment decisions. Biomarkers have proved to be useful for the diagnosis and prognosis of many diseases, and over the years, many biomarkers have been propos...
Main Authors: | Raisa Kraaijvanger, Montse Janssen Bonás, Adriane D. M. Vorselaars, Marcel Veltkamp |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01443/full |
Similar Items
-
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
by: Vivienne Kahlmann, et al.
Published: (2020-10-01) -
Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
by: Yasuaki Kotetsu, et al.
Published: (2021-09-01) -
Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis
by: Nicol Bernardinello, et al.
Published: (2021-08-01) -
RELIABILITY OF BRONCHOALVEOLAR LAVAGE FLUID LYMPHOCYTES COUNT AND BLOOD NEOPTERIN LEVELS AS INFLAMMATORY MARKERS IN SARCOIDOSIS
by: S. A. Terpigorev, et al.
Published: (2016-02-01) -
Early Interleukin-22 and Neutrophil Proteins Are Correlated to Future Lung Damage in Children With Cystic Fibrosis
by: Julie Renwick, et al.
Published: (2021-03-01)